Active Biotech develops innovative pharmaceuticals that modulate the body's own immune system.We focus on widespread diseases for which a tremendous need is felt for new and more effective treatments.

2010-02-26	Number of shares and votes in Active Biotech
2010-02-11	Active Biotech AB Year-end Report, January - December 2009
2010-02-10	Exploratory data presented for Active Biotech's ANYARA project
2010-02-10	Exploratory data presented for Active Biotech's ANYARA project
2010-02-08	TEVA ACQUIRES MARKETING RIGHTS FOR ORAL LAQUINIMOD IN THE NORDIC AND BALTIC REGIONS
2009-12-14	Primary endpoint reached in Active Biotech's TASQ Phase II clinical trial in prostate cancer patients

Active Biotech AB, Scheelevägen 22, P.O. Box 724, SE-220 07 Lund, Sweden, Telephone +46 46 19 20 00